Medicines and Healthcare products Regulatory Agency. (2026) Drug safety update (DSU). Improving information supplied with gabapentinoids (pregabalin/gabapentin), benzodiazepines and z-drugs. London: Medicines and Healthcare products Regulatory Agency.

Medicines and Healthcare products Regulatory Agency. (2025) Prolonged-release opioids: removal of indication for relief of post-operative pain. MHRA Safety Update, 18, (8),

Medicines and Healthcare products Regulatory Agency. (2020) Opioids: risk of dependence and addiction. Drug Safety Update, 14, (2),

Medicines and Healthcare products Regulatory Agency. (2020) Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression. London: Gov.UK.